跳至主要内容
临床试验/DRKS00030724
DRKS00030724尚未招募不适用

Pilot and evaluate the feasibility of an online intervention for LFS sufferers - OnLiFe

niversitätsklinikum Würzburg0 个研究点目标入组 20 人开始时间: 2023年6月9日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Diagnosis Li-Fraumeni syndrome, (probably) pathogenic TP53 germline variant.
  • - Minimum age: 18 years
  • - German as native language or very good knowledge of German
  • - Informed written consent to participate in the study is required.
  • - Safe handling and unrestricted access to laptop, PC, smartphone or tablet

排除标准

  • - Unclassified variant in the TP53 gene (VUS)
  • - Under current treatment for cancer (e.g. immunotherapy, chemotherapy, radiation)
  • - Lack of signed informed consent
  • - Lack of capacity to give consent
  • - Insufficient knowledge of German
  • - Insufficient technical equipment or ability
  • - Limited legal capacity or similar impairments
  • - Physical or mental impairment that makes it impossible to answer questionnaires or independently conduct an online intervention

研究者

发起方
niversitätsklinikum Würzburg

相似试验